Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 601–700 of 898
Réhabilitation respiratoire des patients souffrant de bronchopneumopathie chronique obstructive
Gayan‐Ramirez, G., & Decramer, M. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2008.12.004 · Cited by 4
Réhabilitation du malade atteint de bronchopneumopathie chronique obstructive
Derom, E., Marchand, É., & Troosters, T. (2007) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/j.annrmp.2007.04.021 · Cited by 4
Changes in Sympathetic Nervous System Activity in Male Smokers After Moderate-Intensity Exercise
Ide, H., & Tabira, K. (2013) · Respiratory Care · doi:10.4187/respcare.02240 · Cited by 4
Essential amino acids to treat sarcopenia in patients with COPD?
Rutten, E. P. A., & Spruit, M. A. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2010.306 · Cited by 4
Murugan, Y., Shrivastav, V. N., & Akurathi, H. K. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04452-3 · Cited by 3
Lenártová, P. (2022) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2022.0232 · Cited by 3
Assessment of body composition parameters in patients with osteoporosis
Podkhvatilina, A. S., Nikitin, I. G., & Павловна, Щ. С. (2023) · Clinical nutrition and metabolism · doi:10.17816/clinutr624192 · Cited by 4
Diagnostic Performance of Sarcopenia Screening Tests in Chronic Lung Disease Patients
Dilektaşlı, A. G., Kerimoğlu, D., Odabaş, A., Doğan, A., Özpehlivan, A., Öztürk, N. A. A., Güçlü, Ö. A., Demirdöğen, E., Çoşkun, F., Ursavaş, A., et al. (2025) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2025.25806 · Cited by 3
Évaluation de la composition corporelle en réanimation : avantages et limites
Thibault, R., & Pichard, C. (2011) · Réanimation · doi:10.1007/s13546-011-0288-1 · Cited by 3
Intérêt du questionnaire de qualité de vie Saint-George chez les patients atteints de BPCO
Beaumont, M. (2010) · Kinésithérapie la Revue · doi:10.1016/s1779-0123(10)74754-9 · Cited by 3
Unveiling the Knowledge Frontier: A Scientometric Analysis of COPD with Sarcopenia
Zou, J., & Peng, W. (2024) · International Journal of COPD · doi:10.2147/copd.s448494 · Cited by 3
Васильевна, Ф. С., Uryasev, O. M., & Belskikh, E. S. (2024) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj202412145-54 · Cited by 3
Taketa, T., Uchiyama, Y., & Domen, K. (2025) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1631 · Cited by 3
Activité physique et nutrition dans la broncho-pneumopathie chronique obstructive
Costes, F., & Pison, C. M. (2014) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2014.10.004 · Cited by 4
Candemir, İ. Ç. (2018) · InTech eBooks · doi:10.5772/intechopen.70920 · Cited by 3
Pedrozo‐Pupo, J. C., Celemin-Güete, G. D. J., & Campo‐Arias, A. (2019) · Universidad y Salud · doi:10.22267/rus.192102.146 · Cited by 3
Muscle weakness assessment in non-hypoxemic COPD out-patients at tertiary care hospitals
Zuberi, F. F., Zuberi, B. F., Ali, F. S., & Bader, N. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.2.3127 · Cited by 3
Mou, K., Chan, S. M. H., Brassington, K., Dobric, A., Luca, S. N. D., Seow, H. J., Selemidis, S., Bozinovski, S., & Vlahos, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.859146 · Cited by 3
Rehabilitation of the patients with pulmonary tuberculosis and tuberculosis sequelae
Chushkin, M., Стручков, П. В., On, O., & Karpina, N. (2022) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2022-100-2-3-91-96 · Cited by 3
Grandio, G., Yetter, G., Briglio, S., Ong, K. J., Froding, J., Kim, J., Cortez, J., & Baydur, A. (2023) · Archives of Rehabilitation Research and Clinical Translation · doi:10.1016/j.arrct.2023.100259 · Cited by 3
The patients with severe Chronic Obstructive Pulmonary Disease and chronic respiratory insufficiency
Ambrosino, N., Digiorgio, M., & Paco, A. D. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2007.486 · Cited by 3
Nardi, R., Corbetta, L., Muratori, M., Belmonte, G., Scanelli, G., & Mathieu, G. (2011) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.01.023 · Cited by 3
Nutritional Status in Aging and Lung Disease
Incalzi, R. A., Scichilone, N., Fusco, S., & Corsonello, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801816-3.00030-3 · Cited by 3
The use of multidimensional indices
Celli, B. R., & Macario, C. C. (2015) · European Respiratory Society eBooks · doi:10.1183/2312508x.10019714 · Cited by 3
Nutrition Therapy in End-Stage Lung Disease
Nguyen, L. P., Gearhart, A. M., Cavallazzi, R., & Allen, K. S. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0218-6 · Cited by 3
Urooj, A., Srigiripura, C. V., Chaya, S. K., & Mahesh, P. A. (2017) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_37_17 · Cited by 3
Танченко, О. А., & Владимировна, Н. С. (2018) · Bulletin physiology and pathology of respiration · doi:10.12737/article_5a9f2b6c723c93.71757652 · Cited by 3
Força muscular, distância percorrida e capacidade pulmonar na Doença Pulmonar Obstrutiva Crônica
Mendonça, D., de Lima, A. M. C., de Araújo, M. S., Pereira, P. M., & de Matos, C. J. O. (2021) · Saúde em Redes · doi:10.18310/2446-4813.2021v7n1p167-177 · Cited by 3
Définitions, classification, facteurs pronostiques
(2010) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(10)70003-6 · Cited by 3
Nutrition in General Practice.
van Wayenburg, C. A. M. (2007) · Radboud Repository (Radboud University) · Cited by 3
Pasqualoto, A. S. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 3
Body composition in COPD; stepping back or moving forward?
Schols, A. M. W. J. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.09.010 · Cited by 3
Self-citationZander, D. S. (2007) · CHEST Journal · doi:10.1378/chest.07-0386 · Cited by 3
Predicting poor prognosis in COPD patients: looking for a lamp lit in the darkness of the night
Crisafulli, E. (2014) · European Respiratory Journal · doi:10.1183/09031936.00045614 · Cited by 3
López-García, A. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 3
Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Badawy, M. S., Mahmoud, A. R., & Mohamed, R. (2018) · European Respiratory Journal · doi:10.1183/13993003.congress-2018.pa4031 · Cited by 3
Shi, J., Li, T., Chen, Z., Su, L., Wu, Q., Zhao, H., & Chen, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1633451 · Cited by 2
Tiucă, L.-C., Gheorghe, G., Ionescu, V. A., Antonie, N. I., & Diaconu, C. C. (2025) · Medicina · doi:10.3390/medicina61112003 · Cited by 2
Oh, J., Park, C. J., Kang, Y., & Ra, S. W. (2025) · Respiratory Research · doi:10.1186/s12931-025-03357-9 · Cited by 2
Lee, H. W., Kim, S. H., Kim, T.-H., Ra, S. W., Lee, W., Byun, M. K., Lee, C., Kim, D. K., Yoo, K. H., & Hwang, Y. I. (2026) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2026-004358 · Cited by 2
Ernährungszustand und Körperzusammensetzung bei COPD – Was wissen wir?
Bösch, D. (2009) · Pneumologie · doi:10.1055/s-0029-1214691 · Cited by 2
An investigation into the efficacy of four nutrition risk screening tools in respiratory patients
Keaskin, L., Corish, C. A., & Barnes, E. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109993508 · Cited by 2
Hariprasath, K., Inba Shyamal, A. R., Shaji, J., & Chandrasekar, C. (2022) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2022.v08i06.007 · Cited by 2
The Role of Specific Nutriments in Sarcopenia Associated With Chronic Diseases
Antoun, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-810422-4.00005-1 · Cited by 2
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency
Rondanelli, M., Gasparri, C., Razza, C., Ferraris, C., Perna, S., Ferrarotti, I., & Corsico, A. G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114753 · Cited by 2
Yakut, H., Eymır, M., Özalevli, S., & Alpaydın, A. Ö. (2023) · Sağlık Bilimleri Dergisi · doi:10.34108/eujhs.1284636 · Cited by 2
Muršić, D., Glunčić, T. J., Ostojić, J., Škrinjarić-Cincar, S., Kardum, L. B., Dokoza, M., Lazarušić, N. K., Bešić, E., Samaržija, M., & Dugac, A. V. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae024 · Cited by 2
Obesity and Chronic Obstructive Pulmonary Disease (COPD)
Franssen, F. M. E. (2024) · Respiratory medicine · doi:10.1007/978-3-031-52696-1_12 · Cited by 2
Chronic oxidative stress and telomere shortening
Houben, J. M. J., Moonen, H. J. J., van Schooten, F., & Hageman, G. J. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.06.013 · Cited by 2
Co-Morbidities and Systemic Effects of COPD
Wouters, E. F. �., & Rutten, E. P. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_13 · Cited by 2
Self-citationMacNee, W., Vestbo, J., & Agustí, A. G. N. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00043-9 · Cited by 2
Jaitovich, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63046-1_8 · Cited by 2
Crisafulli, E., Costi, S., & Clini, E. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1788-1_145 · Cited by 2
Ghrelin in Cachexia Associated with End-Stage Renal Disease
Ashby, D. R., Choi, P., & Bloom, S. R. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-903-7_13 · Cited by 2
Treatment of obstructive airway diseases with roflumilast, a novel phosphodiesterase 4 inhibitor
Bardin, P. G. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.469 · Cited by 2
[Nutritional depletion in chronic obstructive pulmonary disease].
Chen, Y., & Yao, W.-Z. (2004) · PubMed · Cited by 2
Aspects of skeletal muscles in chronic respiratory disease
Man, W. D. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972316653541 · Cited by 2
Chronic Obstructive Pulmonary Disease: A Nutrition Review
Thomas, D. R. (2009) · CRC Press eBooks · doi:10.1201/9781420067637.ch9 · Cited by 2
Fonseca, F. R., Karloh, M., de Araújo, C. L. P., dos Santos, K., & Mayer, A. F. (2016) · Revista de Nutrição · doi:10.1590/1678-98652016000500002 · Cited by 2
Nutrition in Pulmonary Rehabilitation
Schols, A. M. W. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-65888-9_11 · Cited by 2
Self-citationVrbica, Ž., Dugac, A. V., Popović Grle, S., Jalušić Glunčić, T., Jakopović, M., Bival, S., Krznarić, Ž., & Samaržija, M. (2018) · Liječnički vjesnik · doi:10.26800/lv-140-7-8-24 · Cited by 2
Recuperación funcional del paciente cardiorrespiratorio
Blanco, A. C. (2019) · Nutrición Hospitalaria · doi:10.20960/nh.02679 · Cited by 2
Targeting Limb Muscle Dysfunction in COPD
Nyberg, A., & Frykholm, E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90815 · Cited by 2
Kawagoshi, A., Iwakura, M., Furukawa, Y., Sugawara, K., Takahashi, H., & Shioya, T. (2020) · Journal of Physical Therapy Science · doi:10.1589/jpts.32.804 · Cited by 2
Meshcheryakova, N. N., & Si, O. (2025) · doi:10.18093/978-5-6052509-2-0-2024-5-146-174 · Cited by 2
Cachexia and Chronic Respiratory Failure: Lessons From Ventilatory Support
Wouters, E. F. �. (2006) · Respiratory Care · doi:10.4187/respcare.06510121 · Cited by 2
Self-citationThe Role Played by Exacerbations in the Natural History of Chronic Obstructive Pulmonary Disease
Soler‐Cataluña, J. J. (2007) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(07)60024-x · Cited by 2
Figueiredo, P. S. (2019) · NVA (Nasjonalt vitenarkiv) · Cited by 2
The need for a national perspective to improve COPD management
Marco, F. D., Pellegrino, G. M., & Papa, G. F. S. (2019) · Jornal Brasileiro de Pneumologia · doi:10.1590/1806-3713/e20190349 · Cited by 2
Suleymanova, A., & Baranova, I. A. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.03.000448 · Cited by 2
Looking Beyond BMI Classifications With Complementary Assessment of Body Composition in COPD
Rozenberg, D., & Maddocks, M. M. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.01.023 · Cited by 2
Geriatric Rehabilitation for older patients with COPD
Dam van Isselt, E. F. V. (2019) · Data Archiving and Networked Services (DANS) · Cited by 2
Alsharaway, L. A. (2019) · Egyptian Journal of Bronchology · doi:10.4103/ejb.ejb_33_19 · Cited by 1
Rôle du poids sur la santé respiratoire
Taillé, C. (2008) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(08)74086-5 · Cited by 1
Investigation of nutritional status and body composition in patients with tuberculosis
Rudnev, S. G., Можокина, Г. Н., Bogorodskaya, E. M., Галыгина, Н. Е., Nikolaev, D. V., & Евгеньевич, Р. О. (2013) · PULMONOLOGIYA · doi:10.18093/0869-0189-2013-0-1-101-107 · Cited by 1
李, 吉. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.126771 · Cited by 1
Shin, H. J., Lee, J. W., Kim, S. H., Shin, M., & Jang, M. H. (2023) · Journal of Electrodiagnosis and Neuromuscular Diseases · doi:10.18214/jend.2023.00024 · Cited by 1
Rubenstein, J., Benlala, I., Mesa, E., Toublanc, A., Guecamburu, M., Maurac, A., Bon, C., Vergnenègre, C., Grassion, L., Moucheboeuf, G., et al. (2025) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2025.101178 · Cited by 1
Brouwer, V. H. E. W., Schuijt, H. J., Vrancken, J. W. F. A., Visser‐Meily, J. M. A., Achterberg, W. P., & van Isselt, E. F. V. D. (2026) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-026-00517-2 · Cited by 1
Fang, H., Zhao, Y., Wang, J., & Wu, H. (2026) · International Journal of COPD · doi:10.2147/copd.s605351 · Cited by 1
CT-Derived Pectoralis Muscle Measurements and All-Cause Mortality in COPD
Lee, K. R., Baek, K., Kim, J. Y., Kwon, Y. S., Hwang, E., Kim, B. J., Lee, M. S., & Hong, J. H. (2026) · Diagnostics · doi:10.3390/diagnostics16111645 · Cited by 1
Kliniczne postępowanie w bardzo ciężkiej postaci POChP
Ambrosino, N., & Simonds, A. K. (2009) · Palliative Medicine in Practice · Cited by 1
The Effect of Fluid Consumption and Exercise on Segmental Bioelectrical Impedance
Backes, T. P., Swartz, C., Conti, A., & Knapp, J. M. (2017) · International Journal of Physical Education Fitness and Sports · doi:10.26524/2017.06.02.2 · Cited by 1
Nutrition, Appetite and Weight Loss in Elders Living in Long-Term Care Facilities
Goodman, K. M. (2014) · IRL - University of Missouri, St. Louis (University of Missouri–St. Louis) · Cited by 1
雄志, 長., 格夫, 佐., Schols, A. M. W. J., STEINER, M. C., & Pison, C. M. (2013) · 静脈経腸栄養 · doi:10.11244/jjspen.28.795 · Cited by 1
Self-citationBuchmann, N., Norman, K., Steinhagen‐Thiessen, E., Demuth, I., & Eckardt, R. (2016) · Zeitschrift für Gerontologie und Geriatrie · Cited by 1
Nutrition and Acute Lung Injury in Critical Care: Focus on Nutrition Care Process
Hanson, C., Rutten, E. P. A., Rollins, C., & Dobak, S. (2015) · Springer eBooks · doi:10.1007/978-1-4614-7836-2_34 · Cited by 1
Covarrubias, D. A., Covarrubias, G. M., & Ho, J. M. (2015) · Springer eBooks · doi:10.1007/978-1-4614-7836-2_7 · Cited by 1
Nutrition and Chronic Obstructive Pulmonary Disease
McKenzie, D. S.-A., & Gray‐Donald, K. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-385-5_20 · Cited by 1
Muscaritoli, M., Lucia, S., & Fanelli, F. R. (2012) · Wiley eBooks · doi:10.1002/9781118338032.ch10 · Cited by 1
Sillen, M. J. H., Vercoulen, J. H. M. M., Hul, A. J. V. ‘., Klijn, P. H. C., Wouters, E. F. �., van Ranst, D., Peters, J. B., van Keimpema, A. R. J., Franssen, F. M. E., Otten, H. J. A. M., et al. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.736310 · Cited by 1
Self-citationMann, R., Dogra, A., Malay, S., & Padam, A. (2014) · National Journal of Medical Research · Cited by 1
Datta, S., Chattopadhyay, S., Das, A. S., & Mitra, C. (2014) · Advances in Research · doi:10.9734/air/2015/13951 · Cited by 1
Kakarla, B., Boddula, R. P., & Gongati, P. K. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20163992 · Cited by 1
Curtis, K. (2016) · Spiral (Imperial College London) · doi:10.25560/44728 · Cited by 1
Celli, B. R. (2015) · Barcelona Respiratory Network · doi:10.23866/brnrev:2015-m0002 · Cited by 1
Jain, R. K., & Vokes, T. (2017) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2017.10.040 · Cited by 1
Assessment of Limb Muscle Function
Rabinovich, R., Bui, K.-L., Nyberg, A., Saey, D., & Maltais, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-65888-9_6 · Cited by 1
Furlanetto, K. C., Hernandes, N. A., & Pitta, F. D. O. (2017) · Springer eBooks · doi:10.1007/978-3-319-65888-9_19 · Cited by 1
Nutrition Care in Internal Medicine
Fukuzawa, Y., Yoshitomi, A., Morita, S., Shiraki, M., Kato, A., Haruta, J., Murakami, M., & Taku, K. (2017) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.106.133 · Cited by 1
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.